Bioanalytical Systems, Inc. (NASDAQ:BASI)

About the company

Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.


Health Services


Services to the Health Industry




Robert Leasure





Total Revenue




Market Capitalization


Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin


Operating Margin (in %)

Total operating margin


Net Margin (in %)

Total net margin


Dividend Yield (in %)

Dividend per share


Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
IQVIA Holdings, Inc. IQV 28708.02 11158.00 5.00 133.02 1.93
Laboratory Corp. of America Holdings LH 16922.64 11587.00 2.39 53.63 2.77
Quest Diagnostics, Inc. DGX 15887.52 7726.00 2.76 18.60 10.33
Syneos Health, Inc. SYNH 5976.28 4720.00 1.97 30.31 4.13
National Research Corp. NRC 1466.40 130.00 38.11 40.29 27.51
Apollo Medical Holdings, Inc. AMEH 577.44 625.00 2.90 32.08 2.89
Bioanalytical Systems, Inc. BASI 54.56 55.00 5.45 -23.62 -3.94
Protalix Biotherapeutics, Inc. PLX 52.35 66.00 -3.67 -5.54 -14.18
Psychemedics Corp. PMD 31.32 35.00 1.83 37.29 2.14
Interpace Biosciences, Inc. IDXG 20.68 27.00 3.06 -0.60 -121.14
Pressure BioSciences, Inc. PBIO 4.50 2.00 -0.52 -0.28 -876.69

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

The next move: After years of turmoil, biotech testing firm aims to grow again

6d ago, source: The Republic

WEST LAFAYETTE — Fourteen months ago, Bioanalytical Systems Inc. made a splash when it appointed a new chief operating officer to oversee operations at its three sites in Indiana and Missouri. The ...

Bioanalytical Systems Inc.

9d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Bioanalytical Systems, Inc. Announces Closing of Oversubscribed

5d ago, source: Bloomberg

Before it's here, it's on the Bloomberg Terminal.

Bioanalytical Testing Services Market

25d ago, source:

DNA and others in biological systems. Various scientific processes depend on precise quantification of drugs and other endogenous substances in the biological samples. The bioanalytical testing ...

POE Immunoassay: Plate-based oligonucleotide electro-chemiluminescent immunoassay for the quantification of nucleic acids in biological matrices

15d ago, source: Nature

Oligonucleotide therapeutics use short interfering RNA (siRNA) or antisense oligonucleotide (ASO) molecules to exploit endogenous systems ... is challenging. Bioanalytical assays are important ...

Bioanalytical Systems Dividend Yield:

16d ago, source: YCharts

The dividend yield measures the ratio of dividends paid / net income. Companies with a higher dividend yield tend to have a business model that allows them to pay out more dividends from net income ...

Insider Buying: The Bioanalytical Systems, Inc. (NASDAQ:BASI) CFO & VP of Finance Just Bought US$59k Worth Of Shares

1mon ago, source: YAHOO!

Even if it's not a huge purchase, we think it was good to see that Beth Taylor, the CFO & VP of Finance of Bioanalytical Systems, Inc. (NASDAQ:BASI) recently shelled out US$59k to buy stock ...

Portfolio items

Follow companies to create your optimal portfolio.
Refresh this page to see your newly added stocks.